Biochemical diagnosis of Wilson's disease: an update

• Published in: Advances in laboratory medicine Vol. 3; no. 2; pp. 103 - 113
• Main Authors: Martínez-Morillo, Eduardo, Bauça, Josep Miquel
• Format: Journal Article
• Language: English
• Published: Germany De Gruyter 01-06-2022
• Subjects: atp7b gene; ceruloplasmin; copper; wilson’s disease; ceruloplasmin; copper; Wilson’s disease; ATP7B gene
• ISSN: 2628-491X; 2628-491X
• DOI: 10.1515/almed-2022-0020

Wilson's disease (WD) is an inherited disorder of copper metabolism caused by mutations in the
gene. This condition is characterized by the accumulation of copper in the liver and other organs and tissues causing hepatic and neuropsychiatric manifestations. This paper reviews the diagnostic performance and limitations of the biochemical tests commonly used to detect this underdiagnosed disease. It also provides some recommendations and suggests a set of standardized laboratory comments. At present, a rapid, simple, reliable biochemical test that confirms diagnosis of WD is not available. However, diagnosis can be established based on serum ceruloplasmin and urinary copper excretion. Total serum copper should be employed with caution, since it has a low negative predictive value. The use of estimated non-ceruloplasmin-bound copper is not recommended. Nevertheless, measured relative exchangeable copper has very high sensitivity and specificity and emerges as a potential gold standard for the biochemical diagnosis of WD. The development of novel assays for WD detection makes this disorder a potential candidate to be included in newborn screening programs.